Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 21:29:100563.
doi: 10.1016/j.invent.2022.100563. eCollection 2022 Sep.

Guided internet-based cognitive behavioral therapy for insomnia in patients with borderline personality disorder: Study protocol for a randomized controlled trial

Affiliations

Guided internet-based cognitive behavioral therapy for insomnia in patients with borderline personality disorder: Study protocol for a randomized controlled trial

S van Trigt et al. Internet Interv. .

Abstract

Borderline personality disorder (BPD) is a highly disabling psychiatric disorder with emotion dysregulation at its core, resulting in affective instability, impulsivity and sometimes self-harming or suicidal behavior. Sleep is increasingly recognized to play a crucial role in emotion regulation. BPD patients often suffer from (severe) insomnia, potentially aggravating symptoms and preventing recovery from BPD. Yet, the effects of insomnia treatments have not been investigated in context of BPD. Guided internet-based cognitive behavioral therapy for insomnia (iCBT-I; i-Sleep) has been proven effective in improving both insomnia and affective symptoms. In this randomized controlled trial among 96 patients with a DSM-5 diagnosis of BPD (or other personality disorder with ≥4 BPD traits) and insomnia symptoms, we will test the effectiveness of iCBT-I before regular BPD treatment starts, during the waitlist period, on BPD symptoms. Patients in the control group monitor their sleep through a sleep diary during the waitlist period and also receive standard BPD treatment after that. Using linear mixed models we will test the hypothesis that the iCBT-I group improves more than the control group on BPD symptoms (primary outcome), insomnia severity, additional subjective and objective sleep variables, emotion regulation, comorbid anxiety and depression complaints, and quality of life. These effects are thought to arise from a direct effect of improved sleep on emotion regulation and a synergistic effect on the consolidation and internalization of the BPD treatment effect. To our knowledge, this is the first trial assessing effectiveness of CBT-I in patients with BPD (traits). The accessibility of the studied intervention greatly facilitates clinical implication in case of positive results.

Keywords: Borderline personality disorder; Cognitive behavioral therapy for insomnia; Insomnia; Internet intervention; Randomized controlled trial; Sleep.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: AvS developed the iCBT-I treatment, but has no commercial interest. SvT, TvdZ, EvS, and HvM have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Flowchart of study procedures. Note. BPD: borderline personality disorder; BPDSI: Borderline Personality Disorder Severity Index; iCBT-I: internet-based cognitive behavioral therapy for insomnia; SCID-5-P: Structured Clinical Interview for DSM-5 Personality Disorders; STEPPS: Systems Training for Emotional Predictability and Problem Solving.
Fig. 2
Fig. 2
Schedule of enrolment, interventions, and assessments. Note. T1 and T2 are 2 months and 8 months after baseline respectively. Use of medication and treatment is additionally assessed between T1 and T2; at 4 months and 6 months.

Similar articles

Cited by

References

    1. American Psychiatric Association . American Psychiatric Press; Washington, DC: 2013. DSM-5: Diagnostic And Statistical Manual of Mental Disorders.
    1. Arntz A., Wibbelink C.J.M. BPDSI-5: Borderline Personality Disorder Severity Index - Version5. 2019. pp. 1–28.
    1. Bastien C.H., Vallières A., Morin C.M. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2:297–307. doi: 10.1016/S1389-9457(00)00065-4. - DOI - PubMed
    1. Batterham P.J., Sunderland M., Carragher N., Calear A.L. Development of the RMT20, a composite screener to identify common mental disorders. BJPsych Open. 2020;6:1–7. doi: 10.1192/bjo.2020.37. - DOI - PMC - PubMed
    1. Berman A.H., Bergman H., Palmstierna T., Schlyter F. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur. Addict. Res. 2005;11:22–31. doi: 10.1159/000081413. - DOI - PubMed

LinkOut - more resources